The widespread use of routine PSA testing led to a rapid increase in the incidence of prostate cancer in the early 1990s in the USA; however, prostate cancer incidence has been declining in recent years with the reduction in routine  PSA testing [15–17]. The gene discussed is KLK3; the disease is prostate cancer.